Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Journal of Neurology
Published in: Journal of Neurology 2/2021

01-02-2021 | Migraine | Journal Club

The use of calcitonin gene related peptide monoclonal antibodies in the difficult to treat migraine population

Authors: T. Cosslett, C. Mitchell

Published in: Journal of Neurology | Issue 2/2021

Login to get access

Excerpt

Migraine is characterised by recurrent severe unilateral headaches often associated with nausea, vomiting, phonophobia, photophobia and other neurological sequelae. It is a significant cause of morbidity, affecting an estimated 1.04 billion people worldwide and is responsible for the second-highest number of years lived with disability worldwide. Despite the on-going development and wide availability of effective treatments for acute attacks as well as prophylaxis, there remains a significant proportion of people with migraine resistant to conventional therapies. …
Metadata
Title
The use of calcitonin gene related peptide monoclonal antibodies in the difficult to treat migraine population
Authors
T. Cosslett
C. Mitchell
Publication date
01-02-2021
Publisher
Springer Berlin Heidelberg
Published in
Journal of Neurology / Issue 2/2021
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-020-10392-7

Other articles of this Issue 2/2021

Journal of Neurology 2/2021 Go to the issue

Original Communication

Polyradiculoneuropathy induced by immune checkpoint inhibitors: a case series and review of the literature

Original Communication

Vestibular impairment in Charcot–Marie–Tooth disease

Correction

Correction to: Refractory anti‑NMDAR encephalitis successfully treated with bortezomib and associated movements disorders controlled with tramadol: a case report with literature review

Original Communication

Change and onset-type differences in the prevalence of comorbidities in people with multiple sclerosis

Original Communication

Common genetic variants in PRRC2A are associated with both neuromyelitis optica spectrum disorder and multiple sclerosis in Han Chinese population

Original Communication

Deep geno- and phenotyping in two consanguineous families with CMT2 reveals HADHA as an unusual disease-causing gene and an intronic variant in GDAP1 as an unusual mutation